Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis

Autor: Bensi, C, Marrodan, M, González, A, Chertcoff, A, Osa Sanz, E, Chaves, H, Schteinschnaider, A, Correale, J, Farez, MF

Publikováno v: In Multiple Sclerosis and Related Disorders October 2018 25:246-250

The Risk of Multiple Sclerosis Relapse After Vaccination: Can a Population-Based Study of Mass Vaccination End the Longstanding Debate?

Autor: Abboud H; From the Multiple Sclerosis and Neuroimmunology Program (H.A.), University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH; and Center for Research on Neuroimmunological Diseases (CIEN) (M.F.F.), Fleni, Buenos Aires, Argentina., Farez MF; From the Multiple Sclerosis and Neuroimmunology Program (H.A.), University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH; and Center for Research on Neuroimmunological Diseases (CIEN) (M.F.F.), Fleni, Buenos Aires, Argentina.

Publikováno v: Neurology [Neurology] 2024 Sep 10; Vol. 103 (5), pp. e209761. Date of Electronic Publication: 2024 Aug 14.

Theory of mind, emotion recognition and emotional reactivity factors in early multiple sclerosis: Results from a South American cohort.

Autor: Crivelli L; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Calandri IL; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Helou B; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Corvalán N; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Fiol MP; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Ysraelit MC; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Gaitan MI; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Negrotto L; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Farez MF; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Allegri RF; Departamento de Neurología, FLENI, Buenos Aires, Argentina., Correale J; Departamento de Neurología, FLENI, Buenos Aires, Argentina.

Publikováno v: Applied neuropsychology. Adult [Appl Neuropsychol Adult] 2024 Mar-Apr; Vol. 31 (2), pp. 162-172. Date of Electronic Publication: 2021 Nov 22.

Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs.

Autor: Silva BA; Centro Universitario de Esclerosis Múltiple (CUEM), Hospital JM Ramos Mejía, Buenos Aires, Argentina; Sección Enfermedades Desmielinizantes, Hospital Italiano de Buenos Aires, Argentina. Electronic address: berenice.silva@gmail.com., Carnero Contentti E; Unidad de Neuroinmunología, Departamento de Neurociencias, Hospital Alemán de Buenos Aires, Argentina., Becker J; Hospital São Lucas - Pontifícia Universidade Católica do Rio Grande do Sul, Brazil., Carranza JI; Sección Zoopatología y Parasitología Médica, Hospital Muñiz, Buenos Aires, Argentina., Correa-Díaz PE; Hospital Militar Escuela Managua, Nicaragua., Galleguillos Goiry L; Clínica Alemana y Universidad del Desarrollo, Santiago, Chile., Garcea O; Centro Universitario de Esclerosis Múltiple (CUEM), Hospital JM Ramos Mejía, Buenos Aires, Argentina., Gracia F; Hospital Santo Tomas, Panama., Hamuy F; Departamento de Neurología, Hospital IMT, Paraguay; Departamento de Neurología de Diagnostico, Codas Thompson, Paraguay., Macías MA; Departamento De Neurociencias, CUCS, Universidad De Guadalajara, México., Navas C; Clínica Enfermedad Desmielinizantes, Clinica Universitaria Colombia, Colombia., Nuñez S; Servicio de Infectología, Sanatorio Güemes, Buenos Aires, Argentina., Rojas JI; Service of Neurology, Hospital Universitario CEMIC, Buenos Aires, Argentina; Centro de Esclerosis Múltiple de Buenos Aires (CEMBA), Buenos Aires, Argentina., Farez MF; CIEN, FLENI, Buenos Aires, Argentina., Alonso R; Centro Universitario de Esclerosis Múltiple (CUEM), Hospital JM Ramos Mejía, Buenos Aires, Argentina; Servicio de Neurología, Sanatorio Güemes, Buenos Aires, Argentina., López P; Unidad de Neuroinmunología, Departamento de Neurociencias, Hospital Alemán de Buenos Aires, Argentina.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Sep; Vol. 77, pp. 104840. Date of Electronic Publication: 2023 Jun 20.

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.

Autor: Tur C; Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Dubessy AL; Sorbonne Université, Inserm, CNRS, UMR7225, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France/ Department of Neurology, Saint Antoine Hospital, AP-HP, Paris, France., Otero-Romero S; Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Amato MP; Department of NEUROFARBA, University of Florence, Florence, Italy/IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy., Derfuss T; Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedicine and Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland., Di Pauli F; Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria., Iacobaeus E; Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Mycko M; Department of Neurology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland., Abboud H; Multiple Sclerosis and Neuroimmunology Program, University Hospitals of Cleveland, Case Western Reserve University School of Medicine, Cleveland Medical Center, Cleveland, OH, USA., Achiron A; Sheba Medical Center at Tel Hashomer and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Bellinvia A; Department of NEUROFARBA, University of Florence, Florence, Italy., Boyko A; Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, Moscow, Russia/Institute of Clinical Neurology and Department of Neuroimmunology, Federal Center of Brain Research and Neurotechnologies, Moscow, Russia., Casanova JL; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA., Clifford D; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA., Dobson R; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK/Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, UK., Farez MF; Center for Research on Neuroimmunological Diseases, FLENI, Buenos Aires, Argentina., Filippi M; Neurology Unit, Neurorehabilitation Unit and Neurophysiology Service, IRCCS San Raffaele Scientific Institute, Milan, Italy/Vita-Salute San Raffaele University, Milan, Italy., Fitzgerald KC; Department of Neurology and Epidemiology, Johns Hopkins University, Baltimore, MD, USA., Fonderico M; Department of NEUROFARBA, University of Florence, Florence, Italy., Gouider R; Department of Neurology, Razi Hospital, Tunis, Tunisia., Hacohen Y; Department of Neuroinflammation, Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, London, UK., Hellwig K; Department of Neurology, St. Josef Hospital, Ruhr-University Bochum, Bochum, Germany., Hemmer B; Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany., Kappos L; Neurologic Clinic and Policlinic, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital, University of Basel, Basel, Switzerland., Ladeira F; Neurology Department, Hospital Santo António dos Capuchos, Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal., Lebrun-Frénay C; CRCSEP Côte d'Azur, CHU de Nice Pasteur 2, UR2CA-URRIS, Université Nice Côte d'Azur, Nice, France., Louapre C; Sorbonne Université, Inserm, CNRS, UMR7225, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France/Sorbonne University, Paris Brain Institute-ICM, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Hôpital de la Pitié Salpêtrière, CIC Neurosciences, Paris, France., Magyari M; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital, Copenhagen, Denmark., Mehling M; Neurology Clinic and Policlinic, Departments of Medicine, Clinical Research and Biomedicine and Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel, University of Basel, Basel, Switzerland., Oreja-Guevara C; Department of Neurology, Hospital Clínico San Carlos, Idissc, Departamento de Medicina, Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain., Pandit L; Center for Advanced Neurological Research, KS Hegde Medical Academy, Nitte (Deemed to be University), Mangalore, India., Papeix C; Sorbonne Université, Inserm, CNRS, UMR7225, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France/Sorbonne University, Paris Brain Institute-ICM, Assistance Publique Hôpitaux de Paris, Inserm, CNRS, Hôpital de la Pitié Salpêtrière, CIC Neurosciences, Paris, France., Piehl F; Division of Neurology, Department of Clinical Neuroscience, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden., Portaccio E; Department of NEUROFARBA, University of Florence, Florence, Italy., Ruiz-Camps I; Servicio de Enfermedades Infecciosas, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Selmaj K; Collegium Medicum, Department of Neurology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland/Center of Neurology, Lodz, Poland., Simpson-Yap S; Clinical Outcomes Research Unit, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, VIC, Australia., Siva A; Department of Neurology, Istanbul University Cerrahpasa School of Medicine, Istanbul, Turkey., Sorensen PS; Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Sormani MP; Department of Health Sciences, University of Genoa and IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari 'Aldo Moro,' Bari, Italy., Vaknin-Dembinsky A; Hadassah-Hebrew University Medical Center, Department of Neurology, The Agnes-Ginges Center for Neurogenetics Jerusalem, Jerusalem, Israel., Vukusic S; Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France/Centre des Neurosciences de Lyon, Observatoire Français de la Sclérose en Plaques, INSERM 1028 et CNRS UMR5292, Lyon, France/Université Claude Bernard Lyon 1, Faculté de médecine Lyon Est, Lyon, France., Weinshenker B; Department of Neurology, Mayo Clinic, Rochester, MN, USA., Wiendl H; Department of Neurology with Institute of Translational Neurology, University of Muenster, Münster, Germany., Winkelmann A; Department of Neurology, University of Rostock, Rostock, Germany., Zuluaga Rodas MI; MS Clinic, Instituto Neurológico de Colombia and Medicarte, Medellin, Colombia., Tintoré M; Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Stankoff B; Sorbonne Université, Inserm, CNRS, UMR7225, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France/ Department of Neurology, Saint Antoine Hospital, AP-HP, Paris, France.

Publikováno v: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2022 Aug; Vol. 28 (9), pp. 1424-1456. Date of Electronic Publication: 2022 Feb 23.